Navigation Links
Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
Date:2/8/2013

BOULDER, Colo., Feb. 8, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer , will present at the Leerink Swann Healthcare Conference in New York.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.(Logo:  http://photos.prnewswire.com/prnh/20121029/LA02195LOGO) Event:Leerink Swann Healthcare Conference Presenter:Ron Squarer, Chief Executive OfficerDate:Thursday, February 14, 2013Time:8:00 a.m. Eastern Time Location:The Waldorf Astoria, New York, NYWebcast:www.arraybiopharma.comAbout Array BioPharmaArray BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. During 2013, Array expects to make substantial progress in generating data to inform registration study decisions for our wholly-owned hematology programs, ARRY-520 and ARRY-614.  Array-invented MEK162 will be tested in a Phase 3 trial in NRAS melanoma which is scheduled to start in April 2013, as well as BRAF mutant melanoma later in 2013 (with Novartis). Also, AstraZeneca recently announced a potential start of a Phase 3 trial with Array-invented selumetinib in non-small cell lung cancer during the second half of 2013.
For more information on Array, please go to www.arraybiopharma.com.

CONTACT: 

Tricia HaugetoArray BioPharma Inc.303-386-1193thaugeto@arraybiopharma.com


'/>"/>
SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
2. Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
3. Array BioPharma Announces Pricing Of Public Offering Of Common Stock
4. Array BioPharma Announces Proposed Public Offering Of Common Stock
5. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
6. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
7. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
8. Matinas BioPharma to Present at the NYC Medical Technology Forum on February 5, 2013
9. Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
10. PDL BioPharma Announces Departure of Finance VP
11. PDL BioPharma Announces 2013 Regular Quarterly Dividends
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences Inc. ... to support the development of CRISPR-Cas3 antimicrobial therapeutics. Financing ... a leading Chinese Internet services provider, and joined by ... multiple infectious disease product programs targeting antibiotic resistant infections ... Founded by Dr. Rodolphe Barrangou and ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral drug ... the Israel Securities Authority to dual-list its common stock on ... commence trading on the TASE on July 12, 2017 under ... the Company, it is expected that Oramed will be included ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... July 24, 2017 , ... ... already work hand-in-hand on an Innovation Collaboration program, have signed a five-year agreement ... and cost of the care members and patients receive. The agreement also signifies ...
(Date:7/24/2017)... Switzerland (PRWEB) , ... July 24, 2017 , ... Anyone ... to weigh a watermelon, nor would a pharmacist using that same scale to dispense ... risk someone’s health. , These illustrations show why it is important to have ...
(Date:7/24/2017)... ... July 24, 2017 , ... A new report ... on delivering end-to-end sleep health care at scale, indicates record-breaking adherence results for ... rates for positive airway pressure (PAP) therapy, the most widely utilized treatment for ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... prestigious StorErotica “Consumer’s Choice” Award, for favorite sex toy. Created in collaboration with ... StorErotica Awards to be consumer voted. The Magic Wand Rechargeable won in stiff ...
(Date:7/24/2017)... ... July 24, 2017 , ... Clinical Quality Assurance:, ... **, Aug. 22-23, 2017 – Arlington, VA, http://www.fdanews.com/cqa , Early bird ... scrutiny and growing demands to track and report adverse events place even greater ...
Breaking Medicine News(10 mins):